Form 4: AngioDynamics CEO James Clemmer Acquires Shares and Stock Options
SEC Form 4
James Clemmer, President and CEO of AngioDynamics, reports acquisition of common stock, performance rights, and stock options.
Summary
- James C. Clemmer, the President and CEO of AngioDynamics Inc., filed a Form 4 detailing changes in beneficial ownership.
- On July 19, 2024, Clemmer acquired 3,817 shares of common stock representing restricted stock units that vest in equal annual installments starting July 19, 2025.
- He also acquired 7,633 performance rights, each representing a contingent right to receive one share of common stock, with the number of shares earned based on total shareholder return relative to a peer group over a three-year period.
- Additionally, Clemmer acquired 7,466 non-qualified stock options with an exercise price of $7.18, vesting in equal annual installments beginning July 19, 2025.
- Following these transactions, Clemmer directly owns 640,387 shares of AngioDynamics common stock, 7,633 performance rights, and 7,466 stock options.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO acquiring shares and options is generally a good sign, but it's a routine part of executive compensation.
Positives
- The CEO's acquisition of shares and stock options could be seen as a positive signal, indicating confidence in the company's future performance.
- The vesting schedules for the restricted stock units and stock options align the CEO's interests with the long-term success of the company.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedules of the acquired securities suggest a long-term commitment from the CEO.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors as they can provide insights into management's view of the company's prospects.
Stakeholder Impact
- The CEO's increased stake in the company could align his interests more closely with those of shareholders.
- Employees may view the CEO's stock acquisitions as a positive sign of company stability and growth potential.
Key Dates
| Date | Description |
|---|---|
| 07/19/2024 | Date of transaction for common stock, performance rights, and stock options acquisition. |
| 07/19/2025 | First vesting date for restricted stock units and stock options. |
| 07/19/2026 | Second vesting date for restricted stock units and stock options. |
| 07/19/2027 | Third vesting date for restricted stock units and stock options. |
| 07/19/2028 | Fourth vesting date for restricted stock units and stock options. |
| 07/19/2034 | Expiration date for the non-qualified stock options. |
| 07/23/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.